Documentation of sample distribution at ALK Abelló
Head of the International Competence Center CRM, ALK-Abelló
All inquiries are now documented. This means that updated and comprehensive information is readily available, even when customer advisors change or when medical aspects must be taken over by other employees.
ALK Abelló - Immune to CRM problems
ALK-Abelló, a global pharmaceutical company focused on allergy vaccination, has been using a CRM solution from the Vienna industry specialist update software since 2005. update.seven supports ALK-Abelló personnel not only in contact management, but it also helps them to fulfill legal obligations: with this software, it is much easier to document the distribution of samples.
Field of application: Sales Force, Sales Support, Marketing, Controlling, Management
Number of users: approx. 400
Solution: update.seven win
- Quick implementation
- Uniform platform
- A single enterprise-wide database
- Continuously updated customer data
- Flexible and user-friendly solution
- Risk management
- Control of sample distribution
- Event Management
Today, update.seven is used predominantly by sales forces all over the world. All employees are notified of new developments so as to provide competent services to their customers. Moreover, Marketing function has been added to the system. The organization, the arrangement and the documentation of events are now also processed by means of the CRM solution. If ALK-Abelló was to choose again, it would definitely make the same decision. The solution has many standard functionalities tailored to the pharmaceutical industry, which require no complex reprogramming. Due to its flexibility and adaptability, the implementation always proves profitable. “Also, for us update is just a reliable business partner”, notes ALK Abelló.
About ALK Abelló
The pharmaceutical enterprise ALK-Abelló is committed to improving the quality of life for allergy sufferers by developing products that target the allergy itself. ALK-Abelló is the world leader in allergy vaccination (immunotherapy). Allergy vaccination is traditionally administered as subcutaneous injections or sublingual droplets. The aim of ALK-Abelló is to extend the use of allergy vaccination by introducing convenient tablet-based vaccines – offering more patients the option of a causal allergy treatment. ALK-Abelló has more than 1,500 employees worldwide. The company is headquartered in Hørsholm, Denmark.